Traditional Chinese medicine composition for preventing and treating simple renal cysts

Abstract

The invention discloses a traditional Chinese medicine composition for preventing and treating simple renal cysts. The traditional Chinese medicine composition comprises the following components in parts by weight: 10-15 parts of thick bark of eucommia, 10-15 parts of dipsacus roots, 10-15 parts of loranthus parasiticus, 10-15 parts of achyranthes bidentata, 20-30 parts of semen plantaginis, 20-30parts of poria cocos, 15-20 parts of corn stigma, 10-15 parts of cowherb seeds, 15-20 parts of chingma abutilon seeds, 5-10 parts of spina gleditsiae, 5-10 parts of rhizoma curcumae, 5-10 parts of fired carapax trionycis and 15-20 parts of radix paeoniae rubra. The invention further disclosed application of the traditional Chinese medicine composition to preparation of a drug for preventing and treating the simple renal cysts and reducing the postoperative recurrence rate of the simple renal cysts. The traditional Chinese medicine composition is a pure traditional Chinese medicine composition, is wide in drug sources, low in cost, small in toxic and side effects, good in curative effect and short in course of treatment, has an obvious curative effect particularly in reducing the recurrence rate of the simple renal cysts, and is suitable for clinical popularization and application.

Description

technical field [0001] The invention belongs to traditional Chinese medicine technology, in particular to a traditional Chinese medicine composition for preventing and treating simple renal cyst. Background technique [0002] Simple renal cysts (SRCs) are common benign lesions in adult kidneys, and the incidence is generally <5%. The pathogenesis of SRCs is not yet fully understood. The incidence of the disease increases with age. The main reason is that the aging of the body is accompanied by the loss of nephrons, and the body compensatory increases the workload of the remaining nephrons, resulting in hypertrophy or hyperplasia of renal tubular cells, which eventually lead to cysts. form. [0003] The current clinical treatment is mainly based on surgical open surgery, B-ultrasound or CT-guided puncture and drainage sclerotherapy and laparoscopic techniques. Surgical open surgery, due to the disadvantages of large trauma, pain, high cost, high incidence of complication...

AI Technical Summary

Problems solved by technology

Surgical open surgery, due to the disadvantages of large trauma, pain, high cost, high incidence of complications and slow recovery, has been rarely used; percutaneous puncture injection of sclerosing agent is better for small cysts, and for larger cysts Cysts, sclerosing agents are not easy to absorb, and the lesions are easy to recur; laparoscopic treatment of simple renal cysts has the advantages of less trauma, quick recovery, and high efficacy. Mastery, need to be performed under general anesthesia, etc., and complications such as retroperitoneal hematoma, damage to surrounding organs, hypercapnia, intestinal obstruction, and internal hernia may occur. diversion to open surgery

B-ultrasound-guided percutaneous fluid aspiration sclerotherapy has been accepted and implemented by many hospitals and patients due to its advantages of less trauma, quick recovery, low cost, and high safety. However, its high recurrence rate is still its main disadvantage compared with surgical operations.

Images